Karlyn A. Martin

1.9k total citations · 2 hit papers
39 papers, 1.0k citations indexed

About

Karlyn A. Martin is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Karlyn A. Martin has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Internal Medicine, 12 papers in Cardiology and Cardiovascular Medicine and 7 papers in Surgery. Recurrent topics in Karlyn A. Martin's work include Venous Thromboembolism Diagnosis and Management (26 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Central Venous Catheters and Hemodialysis (5 papers). Karlyn A. Martin is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (26 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Central Venous Catheters and Hemodialysis (5 papers). Karlyn A. Martin collaborates with scholars based in United States, Netherlands and Norway. Karlyn A. Martin's co-authors include Stephan Moll, Menno V. Huisman, Per Morten Sandset, Bruce L. Davidson, Jan Beyer‐Westendorf, Nigel S. Key, Sadiya S. Khan, Brady L. Stein, Michael J. Cuttica and Bruce L. Davidson and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Karlyn A. Martin

33 papers receiving 991 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH

2016 328 citations Karlyn A. Martin, Jan Beyer‐Westendorf et al. Journal of Thrombosis and Haemostasis profile →
Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation

2021 131 citations Karlyn A. Martin, Jan Beyer‐Westendorf et al. Journal of Thrombosis and Haemostasis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karlyn A. Martin United States	13	703	672	170	151	104	39	1.0k
Alessandra Malato Italy	18	543 0.8×	384 0.6×	227 1.3×	281 1.9×	140 1.3×	59	940
S. Siragusa Italy	12	522 0.7×	291 0.4×	260 1.5×	199 1.3×	121 1.2×	22	730
Marc Carrier Canada	9	784 1.1×	539 0.8×	245 1.4×	222 1.5×	60 0.6×	15	891
Eugenio Bucherini Italy	14	778 1.1×	538 0.8×	393 2.3×	174 1.2×	24 0.2×	28	960
Nuala Peter Germany	8	715 1.0×	694 1.0×	153 0.9×	141 0.9×	15 0.1×	10	935
Sergio Siragusa Italy	14	614 0.9×	430 0.6×	291 1.7×	271 1.8×	94 0.9×	28	829
Corrado Pattacini Italy	13	702 1.0×	577 0.9×	267 1.6×	507 3.4×	41 0.4×	24	1.1k
Colin Chesterman Australia	4	735 1.0×	567 0.8×	353 2.1×	204 1.4×	25 0.2×	4	940
L. Crippa Italy	14	406 0.6×	255 0.4×	221 1.3×	291 1.9×	27 0.3×	24	743
Johan Elf Sweden	16	400 0.6×	254 0.4×	208 1.2×	112 0.7×	17 0.2×	41	680

Countries citing papers authored by Karlyn A. Martin

Since Specialization

Citations

This map shows the geographic impact of Karlyn A. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karlyn A. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karlyn A. Martin more than expected).

Fields of papers citing papers by Karlyn A. Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karlyn A. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karlyn A. Martin. The network helps show where Karlyn A. Martin may publish in the future.

Co-authorship network of co-authors of Karlyn A. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Karlyn A. Martin. A scholar is included among the top collaborators of Karlyn A. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karlyn A. Martin. Karlyn A. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sparks, Andrew, Nicholas S. Roetker, Hanny Al‐Samkari, et al.. (2025). Anticoagulation and other risk factors for clinically relevant bleeding after medical hospitalization: the Medical Inpatient Thrombosis and Hemostasis Study. Journal of Thrombosis and Haemostasis. 23(7). 2122–2132. 1 indexed citations

Thomas, Ryan M., Andrew Sparks, Allen B Repp, et al.. (2025). Risk factors for venous thrombosis after discharge from medical hospitalizations: the Medical Inpatient Thrombosis and Hemostasis study. Journal of Thrombosis and Haemostasis. 23(7). 2190–2197. 1 indexed citations

Martin, Karlyn A., Kenzie A. Cameron, Jeffrey A. Linder, & Lisa R. Hirschhorn. (2024). Preventing venous thromboembolism for ambulatory patients with cancer: Developing the form and content of implementation strategies. SHILAP Revista de lepidopterología. 15. 100168–100168. 1 indexed citations

Martin, Karlyn A., Andrew Sparks, Roger J. Packer, et al.. (2024). Impact of Hospital-Acquired Venous Thromboembolism on Surviving Medical Admission: Findings from the Medical Inpatient Thrombosis and Hemostasis Study. Blood. 144(Supplement 1). 3704–3704.

Groat, Danielle, Karlyn A. Martin, Rachel Rosovsky, et al.. (2023). Primary Care Clinicians’ Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism Treatment. Journal of Clinical Medicine. 13(1). 96–96.

Martin, Karlyn A., et al.. (2023). Rural-urban differences in pulmonary embolism mortality by race-ethnicity and sex in the United States, 1999–2020. Journal of Thrombosis and Thrombolysis. 57(2). 337–340. 2 indexed citations

Martin, Karlyn A., Nicola Lancki, M. Elaine Eyster, et al.. (2023). DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network. Journal of Thrombosis and Thrombolysis. 55(4). 685–690. 10 indexed citations

Martin, Karlyn A., et al.. (2023). Venous thromboembolism prevention in cancer care: implementation strategies to address underuse. Research and Practice in Thrombosis and Haemostasis. 7(7). 102173–102173. 5 indexed citations

Mylvaganam, Ruben, Romy Lawrence, Farbod N. Rahaghi, et al.. (2023). Differences in referral to a chronic thromboembolic pulmonary hypertension center following acute pulmonary embolism: a locoregional experience. Journal of Thrombosis and Thrombolysis. 55(4). 691–699. 3 indexed citations

10.

Martin, Karlyn A., Anaadriana Zakarija, Dinee C. Simpson, et al.. (2023). Hereditary thrombotic thrombocytopenic purpura acquired through liver transplantation: A case report. American Journal of Transplantation. 23(3). 437–439.

11.

Xiao, Nicholas, J. Karp, Robert J. Lewandowski, et al.. (2022). Inferior Vena Cava Thrombosis Risk in 1582 Patients with Inferior Vena Cava Filters. Radiology. 303(2). 300–302. 7 indexed citations

12.

Martin, Karlyn A., Katharine Harrington, Xiaoning Huang, & Sadiya S. Khan. (2022). Pulmonary embolism–related mortality during the COVID‐19 pandemic: Data from the United States. Research and Practice in Thrombosis and Haemostasis. 6(8). e12845–e12845. 1 indexed citations

13.

Groat, Danielle, Karlyn A. Martin, Rachel Rosovsky, et al.. (2022). Physician perceptions and use of reduced‐dose direct oral anticoagulants for extended phase venous thromboembolism treatment. Research and Practice in Thrombosis and Haemostasis. 6(4). e12740–e12740. 2 indexed citations

14.

Martin, Karlyn A., Jan Beyer‐Westendorf, Bruce L. Davidson, et al.. (2021). Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation. Journal of Thrombosis and Haemostasis. 19(8). 1874–1882. 131 indexed citations breakdown →

15.

Kaplan, Rachel M., Yoshihiro Tanaka, Rod Passman, et al.. (2020). Efficacy and Safety of Direct Oral Anticoagulants for Atrial Fibrillation Across Body Mass Index Categories. Journal of the American Heart Association. 9(24). e017383–e017383. 12 indexed citations

16.

Derebail, Vimal K., Karlyn A. Martin, Russell P. Grant, et al.. (2020). Clinical Pharmacology of Apixaban in Nephrotic Syndrome. Journal of the American Society of Nephrology. 31(10S). 722–722. 1 indexed citations

17.

Martin, Karlyn A., Rebecca Molsberry, Sadiya S. Khan, et al.. (2020). Preventing venous thromboembolism in oncology practice: Use of risk assessment and anticoagulation prophylaxis. Research and Practice in Thrombosis and Haemostasis. 4(7). 1211–1215. 23 indexed citations

18.

Moll, Stephan, Daniel J. Crona, & Karlyn A. Martin. (2018). Direct oral anticoagulants in extremely obese patients: OK to use?. Research and Practice in Thrombosis and Haemostasis. 3(2). 152–155. 27 indexed citations

19.

Martin, Karlyn A., Craig R. Lee, Timothy M. Farrell, & Stephan Moll. (2017). Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance. The American Journal of Medicine. 130(5). 517–524. 80 indexed citations

20.

Martin, Karlyn A., Jan Beyer‐Westendorf, Bruce L. Davidson, et al.. (2016). Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 14(6). 1308–1313. 328 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact